Skip to main content
. 2015 Aug 13;6:168. doi: 10.3389/fphar.2015.00168

Figure 2.

Figure 2

HDAC inhibitors (HDIs) significantly increase SUR2 expression in HL-1 cells but not MIN6 cells. (A) HDAC inhibition with trichostatin A (TSA) caused a marked, dose-dependent, increase in SUR2 expression, while SUR1 expression is essentially unchanged (n = 3–10). (B) Like TSA (30 ng/mL), another HDI, romidepsin (5 nM), caused an increase in SUR2 expression in HL-1 cardiomyocytes with little change in SUR1. In contrast, neither TSA nor romidepsin affected SUR subunit expression in MIN6 pancreatic β-cells (n = 5).